- Home
- EDSA vs CREV Comparison
EDSA vs CREV Comparison
Compare EDSA & CREV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- CREV
- Stock Information
- Founded
- EDSA 2015
- CREV 2007
- Country
- EDSA Canada
- CREV Ireland
- Employees
- EDSA N/A
- CREV N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- CREV
- Sector
- EDSA Health Care
- CREV
- Exchange
- EDSA Nasdaq
- CREV Nasdaq
- Market Cap
- EDSA 6.2M
- CREV 7.2M
- IPO Year
- EDSA N/A
- CREV N/A
- Fundamental
- Price
- EDSA $2.31
- CREV $2.38
- Analyst Decision
- EDSA Strong Buy
- CREV Strong Buy
- Analyst Count
- EDSA 1
- CREV 1
- Target Price
- EDSA $21.00
- CREV $39.00
- AVG Volume (30 Days)
- EDSA 22.4K
- CREV 14.2K
- Earning Date
- EDSA 05-09-2025
- CREV 01-01-0001
- Dividend Yield
- EDSA N/A
- CREV N/A
- EPS Growth
- EDSA N/A
- CREV N/A
- EPS
- EDSA N/A
- CREV N/A
- Revenue
- EDSA N/A
- CREV $39,261,077.00
- Revenue This Year
- EDSA N/A
- CREV $40.76
- Revenue Next Year
- EDSA N/A
- CREV $86.18
- P/E Ratio
- EDSA N/A
- CREV N/A
- Revenue Growth
- EDSA N/A
- CREV 41.52
- 52 Week Low
- EDSA $1.55
- CREV $2.00
- 52 Week High
- EDSA $5.59
- CREV $17.15
- Technical
- Relative Strength Index (RSI)
- EDSA 46.68
- CREV 32.79
- Support Level
- EDSA $2.31
- CREV $2.64
- Resistance Level
- EDSA $2.54
- CREV $3.11
- Average True Range (ATR)
- EDSA 0.12
- CREV 0.26
- MACD
- EDSA -0.03
- CREV -0.01
- Stochastic Oscillator
- EDSA 27.48
- CREV 6.96
Stock Price Comparison Chart: EDSA vs CREV
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.